Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer nanobiotechnolgy.

Literature DB >> 28569768

Cancer nanobiotechnolgy.

Yong-Zhuo Huang, Ya-Ping Li.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2017 PMID： 28569768 PMCID： PMC5520198 DOI： 10.1038/aps.2017.48

Source DB: PubMed Journal: Acta Pharmacol Sin ISSN： 1671-4083 Impact factor: 6.150

× No keyword cloud information.

21 in total

1. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.

Authors: Xue-Jia Kang; Hui-Yuan Wang; Hui-Ge Peng; Bin-Fan Chen; Wen-Yuan Zhang; Ai-Hua Wu; Qin Xu; Yong-Zhuo Huang
Journal: Acta Pharmacol Sin Date: 2017-05-08 Impact factor: 6.150

Review 2. Recent advances in peptide nucleic acid for cancer bionanotechnology.

Authors: Jun-Chen Wu; Qing-Chun Meng; Hong-Mei Ren; Hong-Tao Wang; Jie Wu; Qi Wang
Journal: Acta Pharmacol Sin Date: 2017-04-17 Impact factor: 6.150

3. Molecular design and synthesis of self-assembling camptothecin drug amphiphiles.

Authors: Andrew G Cheetham; Yi-An Lin; Ran Lin; Honggang Cui
Journal: Acta Pharmacol Sin Date: 2017-03-06 Impact factor: 6.150

4. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.

Authors: Yan-Na Cui; Qing-Xing Xu; Pooya Davoodi; De-Ping Wang; Chi-Hwa Wang
Journal: Acta Pharmacol Sin Date: 2017-05-29 Impact factor: 6.150

5. Molecular tumor targeting of gelonin by fusion with F3 peptide.

Authors: Song-Hee Ham; Kyoung Ah Min; Meong Cheol Shin
Journal: Acta Pharmacol Sin Date: 2017-04-17 Impact factor: 6.150

6. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.

Authors: Tian Zhang; Preethy Prasad; Ping Cai; Chunsheng He; Dan Shan; Andrew Michael Rauth; Xiao Yu Wu
Journal: Acta Pharmacol Sin Date: 2017-02-20 Impact factor: 6.150

Review 7. Therapeutic gene editing: delivery and regulatory perspectives.

Authors: Gayong Shim; Dongyoon Kim; Gyu Thae Park; Hyerim Jin; Soo-Kyung Suh; Yu-Kyoung Oh
Journal: Acta Pharmacol Sin Date: 2017-04-10 Impact factor: 6.150

8. Two birds, one stone: dual targeting of the cancer cell surface and subcellular mitochondria by the galectin-3-binding peptide G3-C12.

Authors: Wei Sun; Lian Li; Li-Jia Li; Qing-Qing Yang; Zhi-Rong Zhang; Yuan Huang
Journal: Acta Pharmacol Sin Date: 2017-01-09 Impact factor: 6.150

Review 9. Engineering exosomes as refined biological nanoplatforms for drug delivery.

Authors: Xin Luan; Kanokwan Sansanaphongpricha; Ila Myers; Hongwei Chen; Hebao Yuan; Duxin Sun
Journal: Acta Pharmacol Sin Date: 2017-04-10 Impact factor: 6.150

10. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy.

Authors: Junseok Lee; Jinhwan Kim; Yeong Mi Lee; Dongsik Park; Sooseok Im; Eun Ho Song; Hansoo Park; Won Jong Kim
Journal: Acta Pharmacol Sin Date: 2017-04-17 Impact factor: 6.150

2 in total

1. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.

Authors: Bing-Bing Zhang; Xiao-Jie Chen; Xu-Dong Fan; Jing-Jing Zhu; Ying-Hui Wei; Hang-Sheng Zheng; Hong-Yue Zheng; Bin-Hui Wang; Ji-Gang Piao; Fan-Zhu Li
Journal: Acta Pharmacol Sin Date: 2021-04-06 Impact factor: 6.150

Review 2. Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers.

Authors: Shruti Rawal; Mayur Patel
Journal: Nanomicro Lett Date: 2021-06-12

2 in total